Correlation Between Sabra Healthcare and Evofem Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sabra Healthcare and Evofem Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sabra Healthcare and Evofem Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sabra Healthcare REIT and Evofem Biosciences, you can compare the effects of market volatilities on Sabra Healthcare and Evofem Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sabra Healthcare with a short position of Evofem Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sabra Healthcare and Evofem Biosciences.

Diversification Opportunities for Sabra Healthcare and Evofem Biosciences

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Sabra and Evofem is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Sabra Healthcare REIT and Evofem Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evofem Biosciences and Sabra Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sabra Healthcare REIT are associated (or correlated) with Evofem Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evofem Biosciences has no effect on the direction of Sabra Healthcare i.e., Sabra Healthcare and Evofem Biosciences go up and down completely randomly.

Pair Corralation between Sabra Healthcare and Evofem Biosciences

If you would invest  1,837  in Sabra Healthcare REIT on September 4, 2024 and sell it today you would earn a total of  0.00  from holding Sabra Healthcare REIT or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy4.76%
ValuesDaily Returns

Sabra Healthcare REIT  vs.  Evofem Biosciences

 Performance 
       Timeline  
Sabra Healthcare REIT 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Sabra Healthcare REIT are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sabra Healthcare may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Evofem Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evofem Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Evofem Biosciences is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Sabra Healthcare and Evofem Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sabra Healthcare and Evofem Biosciences

The main advantage of trading using opposite Sabra Healthcare and Evofem Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sabra Healthcare position performs unexpectedly, Evofem Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evofem Biosciences will offset losses from the drop in Evofem Biosciences' long position.
The idea behind Sabra Healthcare REIT and Evofem Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing